tesaglitazar interacts_with heart
Evidence from:
primary |
all sources
Evidence (1 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
little effect of tesaglitazar except in the heart (which showed a lowering, normalization of R f*)
confidence: 0.85